I am/have/had
I am looking for
Advanced Filters
Found 2 clinical trials
Study to Evaluate the Pharmacokinetics (PK) of E7090 and Its Metabolite in Participants With Mild and Moderate Hepatic Impairment Compared to Healthy Participants
The primary purpose of the study is to evaluate the effects of mild and moderate hepatic impairment on PK of E7090 after a single dose administration.
body mass index
moderate hepatic impairment
e7090
hepatic impairment
moderate hepatic insufficiency
- 0 views
- 19 Feb, 2024
The Effect of Hepatic Impairment on Aprocitentan Pharmacokinetics
This is a prospective, single-center, open-label, single-dose, Phase 1 study, to assess the effect of moderate hepatic impairment due to liver cirrhosis on the pharmacokinetics of aprocitentan (ACT-132577).
moderate hepatic impairment
systolic blood pressure
follicle stimulating hormone
bilateral salpingectomy
diastolic blood pressure
- 0 views
- 19 Feb, 2024